1. Home
  2. ATAI vs TCBX Comparison

ATAI vs TCBX Comparison

Compare ATAI & TCBX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ATAI
  • TCBX
  • Stock Information
  • Founded
  • ATAI 2018
  • TCBX 2008
  • Country
  • ATAI Germany
  • TCBX United States
  • Employees
  • ATAI N/A
  • TCBX N/A
  • Industry
  • ATAI Biotechnology: Pharmaceutical Preparations
  • TCBX Banks
  • Sector
  • ATAI Health Care
  • TCBX Finance
  • Exchange
  • ATAI Nasdaq
  • TCBX Nasdaq
  • Market Cap
  • ATAI 444.7M
  • TCBX 481.8M
  • IPO Year
  • ATAI 2021
  • TCBX 2021
  • Fundamental
  • Price
  • ATAI $4.57
  • TCBX $39.84
  • Analyst Decision
  • ATAI Strong Buy
  • TCBX Hold
  • Analyst Count
  • ATAI 3
  • TCBX 4
  • Target Price
  • ATAI $13.33
  • TCBX $39.00
  • AVG Volume (30 Days)
  • ATAI 6.3M
  • TCBX 71.3K
  • Earning Date
  • ATAI 08-14-2025
  • TCBX 07-23-2025
  • Dividend Yield
  • ATAI N/A
  • TCBX N/A
  • EPS Growth
  • ATAI N/A
  • TCBX 52.43
  • EPS
  • ATAI N/A
  • TCBX 3.28
  • Revenue
  • ATAI $2,309,000.00
  • TCBX $182,318,000.00
  • Revenue This Year
  • ATAI $423.05
  • TCBX $23.66
  • Revenue Next Year
  • ATAI N/A
  • TCBX $6.46
  • P/E Ratio
  • ATAI N/A
  • TCBX $11.72
  • Revenue Growth
  • ATAI 510.85
  • TCBX 20.25
  • 52 Week Low
  • ATAI $1.03
  • TCBX $23.01
  • 52 Week High
  • ATAI $4.74
  • TCBX $40.35
  • Technical
  • Relative Strength Index (RSI)
  • ATAI 70.54
  • TCBX 66.81
  • Support Level
  • ATAI $3.60
  • TCBX $36.82
  • Resistance Level
  • ATAI $4.23
  • TCBX $39.15
  • Average True Range (ATR)
  • ATAI 0.33
  • TCBX 1.10
  • MACD
  • ATAI -0.01
  • TCBX 0.05
  • Stochastic Oscillator
  • ATAI 85.09
  • TCBX 89.26

About ATAI ATAI Life Sciences N.V.

ATAI Life Sciences NV is a clinical-stage biopharmaceutical company on a mission to develop effective mental health treatments to transform patient outcomes. The company's pipeline of psychedelic-based therapies includes VLS-01 (buccal film DMT) for treatment-resistant depression (TRD) and EMP-01 (oral R-MDMA) for social anxiety disorder. It is also advancing a drug discovery program to identify novel, non-hallucinogenic 5-HT2AR agonists for TRD.

About TCBX Third Coast Bancshares Inc.

Third Coast Bancshares Inc is a bank holding company. It focuses on providing commercial banking solutions to small and medium-sized businesses and professionals with operations in its markets. The bank operates eleven branches in the Greater Houston, Dallas-Fort Worth, and Austin-San Antonio markets, and one branch in Detroit, Texas. The company operates through one segment, community banking, It generates the majority of its revenue from interest on loans, customer service, and loan fees.

Share on Social Networks: